UK Biotechs Look Destined To Remain Bit Players

GW Pharma And Kymab Sold In Less Than A Month

 
• By Kevin Grogan
snail
US biotechs leave the UK in their trail in the race for funding • Source: Shutterstock

More from Deals

More from Business